JILL NIX: Open Payments
NPI 1972781474 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,087 in 92 payments from 16 companies in 2025. Trend: 2023 $1,404 · 2024 $2,079 · 2025 $2,087
Food & beverage: $1,975Education: $112
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $500 |
| ABBVIE INC. | 15 | $442 |
| Novartis Pharmaceuticals Corporation | 25 | $283 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $219 |
| Galderma Laboratories, L.P. | 10 | $203 |
| UCB, Inc. | 5 | $160 |
| GENZYME CORPORATION | 3 | $62 |
| Arcutis Biotherapeutics, Inc. | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 2 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30 |
Products named: TREMFYA, SKYRIZI, RINVOQ, NEMLUVIO, COSENTYX, Bimzelx, ILUMYA, DUPIXENT.
Industry payments across KY — which companies pay providers there.
